Skip to main content
OpenTrials

Clinical trial condition

Carcinoma in Situ

Explore clinical trials studying Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

304 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma in Situ trial results

Recruiting

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

NCT06184750

Conditions
Adenocarcinoma, Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, +17 more
Locations
  • University of Arizona Cancer Center - Prevention Research Clinic Tucson, Arizona, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Illinois College of Medicine - Chicago Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
View Trial Details
Recruiting

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

NCT06075953

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Berkeley Outpatient Center Berkeley, California, United States
  • City of Hope -Duarte Cancer Center Duarte, California, United States
  • City of Hope - Lennar Foundation Cancer Center Irvine, California, United States
  • UCLA Los Angeles, California, United States
View all 28 locations
View Trial Details
Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

NCT04797299

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Carcinoma, +7 more
Locations
  • Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Abbotsford Centre Abbotsford British Columbia, British Columbia, Canada
  • BC Cancer - Centre for the North (Prince George) Prince George, British Columbia, Canada
View all 25 locations
View Trial Details
Recruiting

Acolbifene Versus Low Dose Tamoxifen for the Prevention of Breast Cancer in Premenopausal Women at High Risk for Development of Breast Cancer

NCT05941520

Conditions
Adenocarcinoma, Breast Atypical Hyperplasia, Breast Carcinoma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Kansas Cancer Center Kansas City, Kansas, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions